I have been following the comments about BLSI, and I thought I'd
add some of my own. I have a significant position in this company
(for me, not to BLSI), and have not been trading in and out, as
the Capital Gains Tax in Canada is absolutely punative.
For a long while, it seemed to have a very good support level at
about $1.00 (US currency, of course), but with the beating the
biotech sector recently took, it does not absolutely suprise me that
BLSI also felt the draft.
There is a good story of grpi and therafectin in the reverse takeover
prospectus last year. In my mind, the drug was a dog. However, I spoke
with the chief scientific officer, and he feels quite differently, and
therefore the huge investment.
I think that the stock price is going to fall a bit further, but when it approaches .60 to .70 it should be accumulated.
DG |
